Publication | Open Access

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

OncologyMet AmplificationMedicinePathologyBronchial NeoplasmMet IhcMet Exon 14Cancer GeneticsMolecular DiagnosticsRadiation OncologyLung CancerCancer Research